025: Genetic and epigenetic drivers of high risk blastemal Wilms tumors

HIPO Investigator:

Prof. Gessler

Prof. Pfister

Supported by: HIPO/NCT-POP

Entity: Wilms tumors


Wegert J, et al.; TP53 alterations in Wilms tumor represent progression events with strong intratumor heterogeneity that are closely linked, but not limited to anaplasia. The Journal of Pathology: Clinical Research 2017

Wegert J et al.; Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors, Cancer Cell 2015

DKFZ Logo 3zu Research en Black Blue sRGB

4c nctlogo 2009

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.